Artificial intelligence stocks linked to ChatGPT, large language models and the broader AI build out are sitting at the crossroads of several forces investors are watching closely, from shifting inflation and interest rate expectations to rising energy costs and changing trade patterns. With central banks signaling data dependent policies and bond yields reacting to oil and geopolitics, many investors are looking for companies that are directly involved in semiconductors, AI software, cloud and transformation. This AI Stocks screener is designed for that task, and this article highlights 3 of the most notable stocks it surfaces for further research.
Overview: Aura Consolidated Group (ASX:AXQ) provides a wide range of digital safety services for consumers in Australia and the United States, including credit monitoring, identity theft protection, online privacy tools, antivirus, VPN, password management, scam prevention and child online safety features such as parental controls and AI based app monitoring and alerts.
Operations: Aura Consolidated Group generates all of its approximately US$192.5 million in revenue from Security Software & Services in Australia.
Market Cap: A$796.9 million
Investors looking at Aura Consolidated Group are seeing a pure play on digital safety, with reported revenue growth of 31.3% over the past year to US$192.5 million and fresh capital from a recent IPO that raised about A$145.2 million. At the same time, the company is still reporting sizeable losses, has less than one year of cash runway and currently funds all liabilities with higher risk borrowing. This heightens dependence on successful execution by a relatively inexperienced board and new executive hires, including a Chief AI Officer. For investors comfortable with early stage risk, the mix of identity security, AI driven monitoring and new leadership could merit further research.
Aura Consolidated Group’s rapid revenue growth and fresh IPO cash are only half the story. The real question is how its balance sheet and cash burn stack up against its ambitions, which is laid out in the Aura Consolidated Group financial health report
Overview: Xero (ASX:XRO) is a cloud based accounting platform that helps small businesses and their advisors handle core finance tasks such as bookkeeping, payroll, payments and tax, supported by add ons like Planday for staff scheduling, Hubdoc for bills and receipts, and AI powered tools for reporting and insights.
Operations: Xero generates NZ$2.75b from providing online solutions for small businesses and their advisors, with revenue spread across Australia, New Zealand, the United Kingdom, the United States and other international markets.
Market Cap: A$11.0b
Investors looking at Xero are really weighing up whether a global, high gross margin platform at the heart of small business accounting can justify a rich P/E while still carrying funding and execution risk. Revenue of NZ$2.75b sits alongside a relatively small net profit, tight margins and a low current ROE, so there is little room for missteps. Xero is actively weaving AI into its JAX platform, analytics tools and integrations with partners such as Microsoft 365, Anthropic and Fresha, which could deepen its role in customers’ workflows. If AI features and subscriber growth do what management intends, the combination of scale, recurring revenue and financial discipline could be powerful. However, the valuation and balance sheet structure mean this is not a low risk set and forget stock.
Growth at Xero is tightly tied to AI and subscription scale, but the rich P/E means every misstep matters. It is worth seeing how the analyst forecasts for Xero could shift the story from here.
Overview: Echo IQ (ASX:EIQ) is an Australia based health technology company that uses artificial intelligence to help cardiologists identify and assess structural heart disease. Its EchoSolv platform provides AI driven risk assessments for conditions such as aortic stenosis, diastolic dysfunction and heart failure.
Operations: Echo IQ currently generates about A$0.09 million in revenue from the development of artificial intelligence software.
Market Cap: A$865.7 million
Echo IQ attracts attention because it operates at the intersection of AI and cardiology, even though it currently has a small revenue base and ongoing losses that are forecast to continue for at least three years. The company is targeting rapid revenue growth from its EchoSolv suite and is starting to report traction with deployments such as Mount Sinai Health System in New York. A research collaboration with Mayo Clinic is intended to help validate its cardiac risk tools in oncology. However, the valuation is already elevated relative to book value, the share price has been volatile and the business is funded entirely by higher risk borrowing. The management team is relatively inexperienced, partly offset by a more seasoned board.
Echo IQ sits at the crossroads of AI hype and tiny current revenue, yet its cardiology focus and hospital traction hint at something bigger. Before the story runs ahead of reality, study the analyst forecasts for Echo IQ
The three AI stocks covered here are just a starting point. The full Artificial Intelligence/ AI Stocks screener surfaces 14 more companies that pair AI exposure with equally compelling narratives around chips, software, cloud and large language models. Use Simply Wall St to identify and analyze the specific catalysts, financial traits and business stories that matter most so you can focus on the AI opportunities that align most closely with your own research priorities.
If Echo IQ or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Fresh ideas move fast, and the stocks with real breakout potential rarely stay under the radar for long. Before momentum flies without you, review these curated screeners and consider your next steps promptly.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com